Treatment for multiple sclerosis

Details for Australian Patent Application No. 2005306399 (hide)

Owner Biogen Idec MA Inc.

Inventors Sandrock, Alfred; Panzara, Michael

Agent Cullens

Pub. Number AU-B-2005306399

PCT Pub. Number WO2006/055871

Priority 60/629,700 19.11.04 US

Filing date 18 November 2005

Wipo publication date 26 May 2006

Acceptance publication date 9 February 2012

International Classifications

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/055871 Priority application(s): WO2006/055871

9 February 2012 Application Accepted

  Published as AU-B-2005306399

7 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005306403-Methods and compositions related to Esculentoside A

2005306397-Antibiotic compounds, compositions and medical uses